Peregrine Pharma (PPHM) Reports In-Line Q3 Loss of 13c/Share
Get Alerts PPHM Hot Sheet
Price: $0.61 --0%
Financial Fact:
Total costs and expenses: 16.69M
Today's EPS Names:
SHIM, KOD, HEWA, More
Financial Fact:
Total costs and expenses: 16.69M
Today's EPS Names:
SHIM, KOD, HEWA, More
Join SI Premium – FREE
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) reported Q3 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $3.28 million versus the consensus estimate of $2.12 million.
For earnings history and earnings-related data on Peregrine Pharmaceuticals, Inc. (PPHM) click here.
For earnings history and earnings-related data on Peregrine Pharmaceuticals, Inc. (PPHM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RH touts 'exceptional' demand for new collections after Q4 results fall short
- VNET Group (VNET) Tops Q4 EPS by 18c, provides guidance
- RH (RH) Misses Q4 EPS by 97c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!